Article
Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer.
Cancer epidemiology - 1 Aug 2012
Lv Ning, Lin Suxia, Xie Zeming, Tang Jun, Ge Qidong, Wu Minqing, Xie Xinhua, Xie Xiaoming, Wei Weidong
Abstract excerpt
AIMS: The epidermal growth factor receptor (EGFR) is an available target of effective anti-EGFR therapy for human breast cancer. KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene, encodes a main downstream signaling molecule in the EGFR pathway. The aim of this study was to asse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.